Lv11
80 积分 2024-08-09 加入
Abstract 1787: Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer
2小时前
求助中
Primary analysis from DS8201-A-U105: A phase 1b, two-part, open-label study of trastuzumab deruxtecan (T-DXd) with nivolumab (nivo) in patients (pts) with HER2-expressing urothelial carcinoma (UC)
2小时前
求助中
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
2小时前
已完结
The Internalization and Intracellular Trafficking of ADCs
3小时前
已完结
HER2 heterogeneity as a predictor of response to neoadjuvant T-DM1 plus pertuzumab: Results from a prospective clinical trial
3小时前
求助中
Targeting HER2 heterogeneity in breast cancer
3小时前
已完结
[Expert consensus on the clinical application of antibody drug conjugates in the treatment of malignant tumors (2023 edition)]
16天前
已完结
Sacituzumab govitecan (SG) versus treatment of physician’s choice (TPC) in patients (pts) with previously treated, metastatic triple-negative breast cancer (mTNBC): Final results from the phase 3 ASCENT study
27天前
已完结
Antibody–drug conjugates for cancer
27天前
已完结
Antibody–drug conjugates for cancer
29天前
已完结
皖公网安备34019202002308
